AstraZeneca withdraws COVID-19 vaccine

AstraZeneca announced it is withdrawing its COVID-19 vaccine due to "a surplus of available updated vaccines" that have arisen since the global pandemic started. 

Known as Vaxzevria, the drug has been one of the main COVID-19 vaccines worldwide since it was first administered in January 2021. But according to the company, the demand has greatly decreased and the drug has not generated revenue since April 2023. 

“As multiple, variant COVID-19 vaccines have … been developed, there is a surplus of available updated vaccines. This has led to a decline in demand for Vaxzevria, which is no longer being manufactured or supplied," the company stated.

Read more: CNN

 

The article presented here is intended to inform you about the broader media perspective on dentistry, regardless of its alignment with the ADA's stance. It is important to note that publication of an article does not imply the ADA's endorsement, agreement, or promotion of its content.